MIRAGE Study: Clinical Outcomes of the Mamba Sirolimus-Eluting PTCA Balloon

Clinical trial NCT07326735 · COMPLETED

Trial details

NCT number: NCT07326735
Sponsor: Frisch Medical Device Private Limited
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))

Start date: 2023-01-11
Primary completion: 2024-01-22
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.